Skip to content

Prevalence of Abnormal Postures in Parkinson's Disease

Prevalence of Abnormal Postures in Parkinson's Disease: an Observational Multicenter Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03573232
Acronym
POSTUREinPD
Enrollment
794
Registered
2018-06-29
Start date
2018-03-07
Completion date
2018-10-07
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease, Pisa Syndrome, Camptocormia, Antecollis, Striatal deformities

Brief summary

Postural abnormalities represent disabling and painful complications in patients with Parkinson's disease (PD). The stooped posture is a typical feature of PD but with advancing of disease more severe body abnormalities can affect people with PD. These deformities include Pisa syndrome, camptocormia, antecollis, scoliosis and striatal deformities related to hand (striatal hand) and/or toes (striatal toes).

Detailed description

Postural abnormalities represent disabling and painful complications in patients with Parkinson's disease (PD). The first postural trunk deviation in PD was first described by James Parkinson himself and recognized as stooped simian appearance, with flexion of the hips and knees, and rounding of the shoulders. Although the stooped posture is a typical feature, more severe spinal misalignment (and deformities) can affect people with PD. These postural deformities include Pisa syndrome (PS), camptocormia (CP), antecollis (AC), scoliosis (S) and striatal deformities related to hand (striatal hand) and/or toes (striatal toes). The prevalence of these postural deformities is variable because several diagnostic criteria have been used to characterize each deformity. Recently, a consensus of diagnostic criteria has been reached in literature permitting us to better mapping the presence of these deformities in people with PD.

Interventions

None listed

Sponsors

Universita di Verona
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participants will be considered enrolled after signing the consent form; 2. Diagnosis of Parkinson's disease;

Exclusion criteria

1. Concomitant neurologic diseases known to negatively affect posture; 2. A history of major spinal surgery or muscle and/or skeletal diseases; 3. Treatment with drugs potentially able to induce abnormal postures; 4. Clinical features consistent with a diagnosis of atypical parkinsonism;

Design outcomes

Primary

MeasureTime frameDescription
The prevalence of postural deformities1 day% of people with Parkinson's disease reporting Pisa syndrome, camptocormia, antecollis, scoliosis and striatal deformities related to hand (striatal hand) and toes (striatal toes).

Secondary

MeasureTime frameDescription
Data of birth1 day(day/month/year);
Sex1 day(male/female)
Body Mass Index1 day(score)
SPECIFIC EVALUATION FOR PATIENTS WITH PARKINSON'S DISEASE • Age at PD onset1 day(years)
Disease duration of PD1 day(years)
Modified Hoehn and Yahr (H&Y);1 dayTotal score of Modified Hoehn and Yahr staging scale. It evaluates the stage of Parkinson's disease. Range= 1 to 5. Higher values represent worse stages of disease.
Unified Parkinson's Disease Rating Scale (UPDRS);1 dayThe Unified Parkinson's Disease Rating Scale evaluates the motor and non-motor symptoms of Parkinson's disease. Range= 0 to 260. Higher values represent worse symptoms of disease.
PD phenotype1 day(rigid acinetic; tremor; mixed type)
Degrees1 day(wall goniometer and pictures with software-based analysis)
Latency to develop one or more postural deformity after PD onset1 day(months)
Postural deformity duration1 day(years)
Laterality of motor symptoms at PD onset1 day(right, left, bilateral);
Clinical asymmetry1 day(number of patients)
Quality of life by means of Parkinson's Disease Questionnaire-8;1 dayParkinson's Disease Questionnaire-8 evaluates quality of life in patients with Parkinson's disease. Range= 0 to 100. Higher values represent worse quality of life.
Latency between PD onset and start of antiparkinsonian therapy1 day(years)
Pharmacologic treatment at disease onset of PD1 day(levodopa; dopaminoagonists; L-Dopa + dopaminoagonist; other therapies)
Ongoing pharmacological therapy1 day(levodopa; dopaminoagonists; L-Dopa + dopaminoagonist; other therapies)
Levodopa equivalent daily dose1 day(mg)
SPECIFIC EVALUATION FOR PATIENTS WITH ABNORMAL POSTURES Type of deformity1 day(Pisa syndrome, camptocormia, anterocollis, scoliosis, striatal deformities)
Comorbilities1 day(heart diseases, malignancies, diabetes, hypertension, mental disorders, obesity, metabolic disorders, cerebrovascular diseases, physical trauma)
Associated medical conditions1 day(osteoporosis, arthrosis, rheumatic diseases, otovestibular disorders)
Visual Analogue Scale (VAS)1 dayVisual Analogue Scale evaluates pain intensity. Range= 0 to 10. Higher values represent higher pain intensity.
The pattern of postural deformity onset1 day(acute, subacute, chronic)
Postural deformity after drug modification1 day(yes/no)
Postural deformity awareness1 day(yes/no)
Head compensation1 day(in case of PS, CP, AC)
Neck head on trunk angle1 day(degrees)
Neck tilt angle1 day(degrees)
Head tilt angle1 day(degrees)
Gaze angle (in case of AC)1 day(degrees)
Ankle and hip flexion (in case of CP)1 day(degrees)
Sensory trick1 day(yes/no)
Postural deformity direction only for PS1 day(right/left)
The presence of metronome sign (in case of PS)1 day(yes, no)
Side of PD symptoms at onset and PS inclination1 day(ipsilateral, contralateral, bilateral)
Side of PD symptoms at onset and hands/feet deformities1 day(ipsilateral, contralateral, bilateral)
Number of falls and direction1 day(number, anterior, posterior, right, left)

Countries

Italy

Contacts

Primary ContactMichele Tinazzi, MD, PhD, Professor
michele.tinazzi@univr.it0458124287
Backup ContactChristian Geroin, PhD
christian.geroin@univr.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026